NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $396,000 | +292.1% | 10,000 | -77.8% | 0.02% | +260.0% |
| Q3 2022 | $101,000 | -88.8% | 45,000 | +118.4% | 0.01% | -84.4% |
| Q2 2022 | $903,000 | -0.1% | 20,600 | +64.8% | 0.03% | +23.1% |
| Q1 2022 | $904,000 | -31.4% | 12,501 | -23.1% | 0.03% | +30.0% |
| Q4 2021 | $1,318,000 | +29.2% | 16,257 | +85.5% | 0.02% | -20.0% |
| Q3 2021 | $1,020,000 | -26.1% | 8,762 | -11.5% | 0.02% | -28.6% |
| Q3 2020 | $1,380,000 | +256.6% | 9,904 | +205.6% | 0.04% | +400.0% |
| Q2 2020 | $387,000 | +20.9% | 3,241 | +1.2% | 0.01% | -61.1% |
| Q1 2020 | $320,000 | +3.2% | 3,201 | -41.0% | 0.02% | +200.0% |
| Q3 2018 | $310,000 | +40.3% | 5,429 | +112.7% | 0.01% | +100.0% |
| Q1 2018 | $221,000 | -76.3% | 2,553 | -74.3% | 0.00% | -72.7% |
| Q1 2017 | $931,000 | – | 9,937 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |